A randomized, double‐blind, placebo‐controlled, multicenter study to evaluate the efficacy and safety of adjunctive cenobamate in Asian patients with focal seizures

Cenobamate 100, 200, and 400 mg/day reduced focal seizures in Asian patients in a dose-related fashion and was generally well tolerated.

Authors

Institutions

Publication Details

Journal
Epilepsia
Published
2025-10-27
DOI
https://doi.org/10.1111/epi.18698
Citations
3
Primary Topic
Epilepsy research and treatment
Type
article
Field-Weighted Citation Impact
4.41

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A randomized, double‐blind, placebo‐controlled, multicenter study to evaluate the efficacy and safety of adjunctive cenobamate in Asian patients with focal seizures

Julien Jung, Sunita N. Misra, Takamichi Yamamoto, Louis Ferrari et al.
3 citations
Epilepsia
Epilepsy research and treatment
4.41
article

A randomized, double‐blind, placebo‐controlled, multicenter study to evaluate the efficacy and safety of adjunctive cenobamate in Asian patients with focal seizures

Julien Jung, Sunita N. Misra, Takamichi Yamamoto, Louis Ferrari, Myung Won Kim, William E. Rosenfeld, Marc Kamin, Eun-Yeong Choe, Jungshin Park, Seung Bong Hong, Dong Chi Zhou, Suiqiang Zhu, Kyoung Heo, Ji Hyun Kim, Xiao‐Rong Liu, Kensuke Kawai, Zhen Hong, Sang Kun Lee, Paul N. Yu, Yong Heui Jeon, Koji Iida
article en
3 citations

Abstract

Cenobamate 100, 200, and 400 mg/day reduced focal seizures in Asian patients in a dose-related fashion and was generally well tolerated.

EpilepsiaVol. 67(2)
Seoul National University (KR), Jichi Medical University (JP), Yonsei University (KR), Sichuan University (CN), Fudan University (CN), Korea University Medical Center (KR), New Generation University College (ET), Hanall Biopharma (South Korea) (KR), West China Hospital of Sichuan University (CN), Second Affiliated Hospital of Guangzhou Medical University (CN), Seirei Mikatabara General Hospital (JP), Center for Children (US), SK Life Science (United States) (US), Hiroshima University Hospital (JP), Huashan Hospital (CN), Tongji Hospital (CN), Korea University (JP), Seoul Sleep Center (KR), Huazhong University of Science and Technology (CN), Guangzhou Medical University (CN)
SK Life Science
Openalex Percentile: Top 5%
Epilepsy research and treatment
4.41
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A randomized, double‐blind, placebo‐controlled, multicenter study to evaluate the efficacy and safety of adjunctive cenobamate in Asian patients with focal seizures — Julien Jung, Sunita N. Misra, et al. · Epilepsia (2025) | TGRS Research Map | TGRS